Dian Diagnostics Group Co.,Ltd.

SZSE:300244.SZ

22 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017201620152014201320122011201020092008
Revenue 12,196.22413,408.3220,282.46913,082.61310,649.1628,453.2076,966.8575,004.1243,823.9811,858.1811,335.11,015.474706.419482.474343.273263.253178.29
Cost of Revenue 8,779.6079,256.19512,745.8118,076.9496,578.7065,735.3994,595.13,332.1342,619.6371,233.461847.784638.651454.143314.211220.299170.167125.686
Gross Profit 3,416.6174,152.1257,536.6595,005.6644,070.4562,717.8082,371.7571,671.991,204.344624.72487.316376.823252.276168.263122.97493.08652.605
Gross Profit Ratio 0.280.310.3720.3830.3820.3220.340.3340.3150.3360.3650.3710.3570.3490.3580.3540.295
Reseach & Development Expenses 276.735432.64638.474424.749319.104211.911166.265131.965101.16278.18257.01433.35322.55110.656000
General & Administrative Expenses 180.016194.192270.882227.778205.658196.051187.387167.377118.52574.15155.70644.10132.71528.43153.20443.81821.152
Selling & Marketing Expenses 494.893543.8981,597.0871,210.426966.374760.775648.651464.185326.827164.115134.381115.84279.11450.16833.42824.10216.448
SG&A 674.909738.091,867.9691,438.2041,172.032956.826836.038631.562445.352238.266190.087159.942111.8378.59986.63267.9237.6
Other Expenses 2,466.942201.228961.484861.911564.857464.43812.67636.58319.10216.3012.6983.617-3.0282.6974.1130.718-0.478
Operating Expenses 3,447.7323,309.9423,467.9262,724.8642,055.9931,633.1751,446.6161,115.625789.393430.244339.196268.003184.019125.54288.04170.39842.249
Operating Income -31.115842.1833,814.9661,837.9352,077.0211,192.446721.398592.902415.852194.54150.217108.22971.59646.42533.85919.2716.975
Operating Income Ratio -0.0030.0630.1880.140.1950.1410.1040.1180.1090.1050.1130.1070.1010.0960.0990.0730.039
Total Other Income Expenses Net -20.711-43.857-279.046-46.938-2.916-3.39612.676-15.145-21.172-8.8812.0933.427.022.5623.041-1.996-3.364
Income Before Tax -51.826798.3262,543.5621,790.9971,317.395771.175734.074629.486434.353210.457152.31111.64973.2648.98637.86119.9586.472
Income Before Tax Ratio -0.0040.060.1250.1370.1240.0910.1050.1260.1140.1130.1140.110.1040.1020.110.0760.036
Income Tax Expense 117.407216.735681.092307.396247.461195.607145.612165.39496.40331.67124.45721.61513.8667.4067.9464.741.968
Net Income -357.278307.4611,434.1911,162.884802.933575.568388.608349.593262.761174.795124.58486.09360.18842.20832.41117.1696.59
Net Income Ratio -0.0290.0230.0710.0890.0750.0680.0560.070.0690.0940.0930.0850.0850.0870.0940.0650.037
EPS -0.580.492.31.871.290.930.710.640.480.360.260.180.130.10.0960.0650.028
EPS Diluted -0.580.492.31.871.290.930.710.640.480.360.260.180.130.10.0960.0650.028
EBITDA 760.6391,860.2333,699.3852,515.9221,880.2491,238.7711,081.815846.285512.229260.422180.191133.83588.1958.45145.83928.34613.311
EBITDA Ratio 0.0620.1390.1820.1920.1770.1470.1550.1690.1340.140.1350.1320.1250.1210.1340.1080.075